Fludarabine Labelled with Fluor 18: A New Radiotracer for Onco-hematology
The CEA and Zionexa have signed an exclusive license agreement for Fludarabine labelled with Fluor 18 ([18F] Fludarabine), an innovative radiopharmaceutical.
The CEA and Zionexa have signed an exclusive license agreement for Fludarabine labelled with Fluor 18 ([18F] Fludarabine), an innovative radiopharmaceutical.
We are pleased to announce our participation in ASCO 2019 was a great success, and the keypoints of the ASCO session : “Are we ready for prime time in molecular imaging of breast cancer?".
Discover Peter Webner's Opinion on the Future of Molecular Imaging in DOTmed News.
Zionexa will be at EANM 2019 in Barcelona, Spain
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.